ClinicalTrials.Veeva

Menu

Exercise, Brain Activity, and Weight Maintenance

Joslin Diabetes Center logo

Joslin Diabetes Center

Status

Enrolling

Conditions

Appetitive Behavior
Weight Gain
Bariatric Surgery Candidate
Obesity

Treatments

Other: Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06511310
00000256

Details and patient eligibility

About

This study aims to explore how HIIT influences brain function, neural and molecular pathways related to weight control, setting the stage for future obesity intervention research.

Full description

This study will include adults aged 18-70 years with a BMI >19 kg/m², both with and without prior bariatric surgery. Those with bariatric surgery must have experienced clinically significant weight regain (>10% of maximum weight lost) within 1 to 5 years post-surgery.

Participants will complete three initial clinical visits before beginning a 12-week high-intensity interval training (HIIT) program, followed by three post-training clinical visits. During visit 1, participants will undergo anthropometric assessments, baseline blood draw, oral glucose tolerance test, psychometric evaluations, and complete an MRI safety screening. At visit 2, participants will complete a resting metabolic rate assessment and a VO₂peak test. During visit 3, participants will have another baseline blood draw and undergo a functional MRI (fMRI).

The HIIT program will consist of four weekly 28-minute sessions conducted at the Joslin Diabetes and at home. Each exercise session will include a 3-minute warm-up, six rounds of 40 seconds high-intensity followed by 3 minutes of moderate intensity, and will conclude with a 3-minute cool-down.

After completing the 12-week program, participants will return for clinical visits 4-6, repeating all baseline assessments.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-70 years
  • Body mass index (BMI) >19 kg/m2 and body weight< 250kg
  • Participants must have experienced a clinically significant weight regain, defined as over 10% of their maximum weight lost, within 1 to 5 years following their bariatric surgery. They will be asked to self-report their weight loss history. Participants must also provide the operative report from their bariatric surgery for reference.
  • In good general health with no conditions that could influence the outcome of the trial, and in the judgment of the investigator is a good candidate for the study based on review of available medical history, physical examination and clinical laboratory evaluations
  • Willing to adhere to the protocol requirements for the duration of the study

Exclusion criteria

  • Type 1 diabetes mellitus
  • Peripheral neuropathy with insensate feet
  • Recent blood donation within the last 2 months
  • Use of beta-blockers
  • Current pregnancy or breastfeeding
  • Active Heart or lung disease
  • Severe hypertension (systolic >160 mmHg or diastolic >90 mmHg)
  • Inability to exercise for any reason
  • Any known contraindication to exercise testing based on current ACSM guidelines
  • MRI contraindications, such as presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments, or foreign objects in the eyes, skin, or body
  • Known presence of a structural brain lesion (e.g. tumor, cortical infarct)
  • Presence of another neurologic disorder, which could impact findings (e.g. multiple sclerosis)
  • History of cardiovascular disease, stroke, congestive heart failure
  • Active hematological, renal, pulmonary or hepatic disorders
  • Active treatment for cancer
  • A history of active alcohol or substance abuse
  • Any significant systemic illness or unstable medical condition which could lead to difficulty complying with the study protocol
  • History of claustrophobia and inability to tolerate an MRI
  • Body weight >250kgr and largest body diameter of 70cm as there is a certain weight and diameter limit of the MRI scanner
  • Unwilling or unable to return for study visits, undergo neuropsychological testing and MRI imaging
  • Left-handedness

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Exercise Training
Experimental group
Description:
Subjects will complete a supervised high-intensity interval training program for 12 weeks, including four weekly training sessions. The training session will include a 3 minute warm-up followed by six 40 second bouts of high intensity (85-95% of VO2peak) with 3 minutes moderate intensity (45-55% of VO2peak) between each bout of high intensity, concluding with a 3 minute cool-down. Each participant's target heart rate will be specific to them, calculated from the exercise test completed during Visit 1.
Treatment:
Other: Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Maria Vamvini, MD; Laura Simpson, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems